New drug cocktail shows promise against tough pancreatic cancer
NCT ID NCT03138720
First seen Apr 23, 2026 · Last updated May 20, 2026 · Updated 5 times
Summary
This study tested a combination of four drugs (paclitaxel protein bound, gemcitabine, cisplatin, and paricalcitol) given before surgery to people with pancreatic cancer that could be removed or was borderline removable. The goal was to see if this treatment could shrink tumors and improve surgery outcomes. Forty patients took part, and researchers measured tumor markers and how many tumors could be completely removed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC ADENOCARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
HonorHealth Research Institute
Scottsdale, Arizona, 85258, United States
Conditions
Explore the condition pages connected to this study.